Vaccine and Infectious Disease Division
Researchers at Fred Hutchinson Cancer Research Center, including several VIDD faculty, received a five-year, $12.5 million award from the National Institute of General Medical Sciences that designates the Seattle campus as a MIDAS Center of Excellence. Models of Infectious Disease Agency Study (MIDAS) centers are designated to play a role in planning for national emergencies such as a pandemic or an act of bioterrorism. Read more »
More Featured News from VIDD »
Uganda offers a unique setting to study the impact of infections on the development and clinical course of several cancers.
More International Programs »
VIDD’s Population Sciences (PS) Program has changed its name to Biostatistics, Bioinformatics, and Epidemiology (BBE).
Fred Hutchinson Cancer Research Center is a world leader in research to prevent, detect
and treat cancer and other life-threatening diseases.